Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle M Kampman

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Addictive Behaviors|April 7, 2009
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependenceKyle M Kampman, Helen M Pettinati, Kevin G Lynch, et al.
Journal of Clinical Psychopharmacology|April 22, 2014
The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot studySubhajit Chakravorty, Alexandra L Hanlon, Samuel T Kuna, et al.
The American Journal of Psychiatry|February 15, 2014
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphismHenry R Kranzler, Jonathan Covault, Richard Feinn, et al.
Journal of Substance Abuse Treatment|October 20, 2022
Not in my treatment center: Leadership's perception of barriers to MOUD adoptionRebecca E Stewart, Nicholas C Cardamone, David S Mandell, et al.
Psychiatric Genetics|November 30, 2005
Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American populationJohn P Dahl, Kyle M Kampman, David W Oslin, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 27, 2005
Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependenceJohn P Dahl, Andrew E Weller, Kyle M Kampman, et al.
Journal of Clinical Psychopharmacology|July 17, 2007
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholismKyle M Kampman, Helen M Pettinati, Kevin G Lynch, et al.
Drug and Alcohol Dependence|September 6, 2021
Analysis of genetic and clinical factors associated with buprenorphine responseRichard C Crist, Rachel Vickers-Smith, Rachel L Kember, et al.
Drug and Alcohol Dependence|April 12, 2003
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction studyCharles A Dackis, Kevin G Lynch, Elmer Yu, et al.
Psychiatric Genetics|September 14, 2006
No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine dependenceAndrew E Weller, John P Dahl, Falk W Lohoff, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Addictive Behaviors|April 7, 2009
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependenceKyle M Kampman, Helen M Pettinati, Kevin G Lynch, et al.
Journal of Clinical Psychopharmacology|April 22, 2014
The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot studySubhajit Chakravorty, Alexandra L Hanlon, Samuel T Kuna, et al.
The American Journal of Psychiatry|February 15, 2014
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphismHenry R Kranzler, Jonathan Covault, Richard Feinn, et al.
Journal of Substance Abuse Treatment|October 20, 2022
Not in my treatment center: Leadership's perception of barriers to MOUD adoptionRebecca E Stewart, Nicholas C Cardamone, David S Mandell, et al.
Psychiatric Genetics|November 30, 2005
Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American populationJohn P Dahl, Kyle M Kampman, David W Oslin, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 27, 2005
Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependenceJohn P Dahl, Andrew E Weller, Kyle M Kampman, et al.
Journal of Clinical Psychopharmacology|July 17, 2007
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholismKyle M Kampman, Helen M Pettinati, Kevin G Lynch, et al.
Drug and Alcohol Dependence|September 6, 2021
Analysis of genetic and clinical factors associated with buprenorphine responseRichard C Crist, Rachel Vickers-Smith, Rachel L Kember, et al.
Drug and Alcohol Dependence|April 12, 2003
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction studyCharles A Dackis, Kevin G Lynch, Elmer Yu, et al.
Psychiatric Genetics|September 14, 2006
No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine dependenceAndrew E Weller, John P Dahl, Falk W Lohoff, et al.
Pageof 9